A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

Dr. Bernick said the new blood test, which was just approved by the FDA, is for adults over the age of 55 who are showing signs of Alzheimer’s disease. Alzheimer’s is the most common cause for ...

The firm's Clinical Viewer is cleared for use with the Hamamatsu NanoZoomer S360MD Slide scanner, NDPI image formats, and the Barco NV MDPC-8127 display.

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

Kinetic measures of a cerebrospinal fluid (CSF) biomarker test predicted cognitive decline in Parkinson's disease and ...

Insight Molecular Diagnostics (Nasdaq: IMDX) moved its headquarters from Irvine, Calif., to Nashville, Tenn., in June 2025. The company’s new NASDAQ symbol became effective June 18. Investors may ...

Northwestern Medicine scientists have uncovered key details about a group of rare but serious blood disorders, which may help inform potential treatments, according to a study published in the Journal ...

The HSE has revealed its intention to carry out a “comprehensive refurbishment and reconfiguration” of part of Ennis General ...

For many animals held captive for research, pain is "not minimized," U.S. Department of Agriculture data shows.

But a new blood test promises to change all that, researchers reported. The test looks for a specific immune response to ...

The pathogenesis of tendinopathy and the primary biological change in the tendon that precipitates pathology have generated several pathoaetiological models in the literature. The continuum model of ...

The test shows early promise as a potential screening ... P<0.0001), independent of high-risk pathology. "Given that our providers were blinded to the MRD results, it remains to be determined ...